Waters will acquire the outstanding capital stock of NuGenesis for approximately $43 million, subject to the satisfaction of conditions contained in a merger agreement. The transaction is expected to be completed in the first quarter of 2004. On a pro-forma basis and prior to giving effect to anticipated acquisition charges, the transaction is not expected to affect Waters 2004 earnings.